Dual Path Platform HIV 1/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria.

HIV/AIDS disease is endemic in Nigeria and associated with stigmatization. Availability of a reliable rapid testing kit and procedure will increase uptake of services. The study aimed to determine the correlation between detection of HIV antibodies in blood to that in oral fluid and to determine the sensitivity and specificity of the Dual Path Platform (DPP) testing kit using oral fluid samples. HIV antibodies detected in oral mucosa transudate and whole capillary blood from HIV-positive, high-risk and low-risk participants were compared with results obtained with whole venous blood from the same participants tested with Determine and Western blot (for discordant cases).

Iregbu KC, Esfandiari J, Nnorom J, Sonibare SA, Uwaezuoke SN, Eze SO, Abdullahi N, Lawal AO, Durogbola BS., Diagn Microbiol Infect Dis. 2011 Apr;69(4):405-9.
http://www.ncbi.nlm.nih.gov
Read more (ext link)